Neuropeptide FF receptor 2
Neuropeptide FF receptor 2 (NPFFR2), also known as G-protein coupled receptor 74 (GPR74), is a protein that in humans is encoded by the NPFFR2 gene. This receptor is a member of the G protein-coupled receptor (GPCR) family, which plays a critical role in signal transduction across cell membranes. NPFFR2 specifically binds to neuropeptides such as Neuropeptide FF and Neuropeptide AF, which are involved in a variety of physiological processes including pain modulation, cardiovascular system regulation, and hormonal regulation.
Function[edit]
NPFFR2 is predominantly expressed in the central nervous system (CNS), including areas such as the hypothalamus and spinal cord, where it is involved in the modulation of pain and the opioid system. Activation of NPFFR2 by its ligands has been shown to produce anti-opioid effects, which can modulate the analgesic effects of opioids and potentially contribute to the development of opioid tolerance. Furthermore, NPFFR2 and its ligands are implicated in the regulation of feeding behavior and energy homeostasis, suggesting a role in the control of body weight and metabolism.
Clinical Significance[edit]
Given its role in pain modulation and the opioid system, NPFFR2 is of interest in the research of new analgesics and treatments for opioid addiction and tolerance. Additionally, due to its involvement in regulating feeding behavior, NPFFR2 is a potential target for the development of treatments for obesity and metabolic disorders.
Ligands[edit]
Several synthetic ligands have been developed to study the function of NPFFR2, including agonists and antagonists. These compounds have been useful in elucidating the physiological and pharmacological roles of NPFFR2, as well as in exploring its potential as a therapeutic target.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
